ClinicalTrials.gg

Mighty Therapeutics clinical trials

Also known as Stealth BioTherapeutics.

Part of Morningside Venture (I) Investments Limited, which holds 66.8% as of 2022-05-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 31 studies whose lead sponsor is Mighty Therapeutics. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Mighty Therapeutics with Hoffmann-La Roche and AbbVie →

Pipeline: 2 programs

Each counted once: 2 with a study Mighty Therapeutics leads registered in the last two years.

  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Mighty Therapeutics’ own registered studies; Mighty Therapeutics’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Mighty Therapeutics’ studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of Mighty Therapeutics’ studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 31 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now310%Not yet recruiting 2 · Recruiting 1
  • Under way, not recruiting13%
  • Completed2271%
  • Stopped early413%Terminated 3 · Withdrawn 1
  • Status unknown or other13%

Phase

  • Phase 215
  • Phase 114
  • Phase 35
  • Phase 41

Where

  • United States23
  • United Kingdom7
  • Hungary6
  • Germany6
  • Italy5
  • Spain4

Over the years

  1. 10
  2. 11
  3. 12
  4. 13
  5. 14
  6. 15
  7. 816
  8. 17
  9. 18
  10. 19
  11. 20
  12. 21
  13. 22
  14. 23
  15. 24
  16. 25
  17. 326

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Mighty Therapeutics.

  • Stealth BioTherapeutics Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    30 studies
  • Mighty Therapeutics, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study

Studies

Recruiting first, then most recently updated. Showing 31 of 31.